EE04941B1 - Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine - Google Patents
Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamineInfo
- Publication number
- EE04941B1 EE04941B1 EEP200200698A EEP200200698A EE04941B1 EE 04941 B1 EE04941 B1 EE 04941B1 EE P200200698 A EEP200200698 A EE P200200698A EE P200200698 A EEP200200698 A EE P200200698A EE 04941 B1 EE04941 B1 EE 04941B1
- Authority
- EE
- Estonia
- Prior art keywords
- schizophrenia
- medicines
- prevention
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000185814 | 2000-06-21 | ||
PCT/JP2001/004934 WO2001098300A1 (fr) | 2000-06-21 | 2001-06-12 | Medicaments utilises dans la prevention et le traitement de maladies neurodegeneratives |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200200698A EE200200698A (et) | 2004-08-16 |
EE04941B1 true EE04941B1 (et) | 2007-12-17 |
Family
ID=18686074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200698A EE04941B1 (et) | 2000-06-21 | 2001-06-12 | Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine |
Country Status (19)
Country | Link |
---|---|
US (1) | US6743803B2 (zh) |
EP (1) | EP1295883A4 (zh) |
KR (1) | KR20030010740A (zh) |
CN (1) | CN100354274C (zh) |
AU (2) | AU6274101A (zh) |
BR (1) | BR0111799A (zh) |
CA (1) | CA2412199A1 (zh) |
CZ (1) | CZ20024153A3 (zh) |
EE (1) | EE04941B1 (zh) |
HU (1) | HUP0301319A3 (zh) |
IL (2) | IL153439A0 (zh) |
MX (1) | MXPA02012599A (zh) |
NO (1) | NO20026148L (zh) |
NZ (1) | NZ523189A (zh) |
PL (1) | PL200537B1 (zh) |
RU (1) | RU2258506C2 (zh) |
SK (1) | SK17682002A3 (zh) |
TW (1) | TWI298068B (zh) |
WO (1) | WO2001098300A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6822097B1 (en) * | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
TW200533371A (en) * | 2004-04-15 | 2005-10-16 | Dainippon Pharmaceutical Co | Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
EP1595881A1 (en) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
WO2010002451A1 (en) * | 2008-07-01 | 2010-01-07 | Concert Pharmaceuticals, Inc. | Naphthyridin derivatives |
JP6551671B2 (ja) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | アルツハイマー治療薬 |
BR112022000811A2 (pt) * | 2019-07-18 | 2022-03-29 | Abaxys Therapeutics | Formulação sólida de um derivado de 1,2,4-oxadiazol |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2683818B1 (fr) | 1991-11-14 | 1993-12-31 | Adir Cie | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
JPH09291034A (ja) * | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピリジン化合物およびその医薬としての用途 |
ZA985870B (en) * | 1997-07-15 | 1999-01-27 | Dainippon Pharmaceutical Co | 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
WO2000073283A1 (en) | 1999-06-02 | 2000-12-07 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
-
2001
- 2001-06-06 TW TW090113656A patent/TWI298068B/zh not_active IP Right Cessation
- 2001-06-12 EP EP01936958A patent/EP1295883A4/en not_active Withdrawn
- 2001-06-12 BR BR0111799-8A patent/BR0111799A/pt not_active Application Discontinuation
- 2001-06-12 AU AU6274101A patent/AU6274101A/xx active Pending
- 2001-06-12 CA CA002412199A patent/CA2412199A1/en not_active Abandoned
- 2001-06-12 IL IL15343901A patent/IL153439A0/xx active IP Right Grant
- 2001-06-12 RU RU2003101405/04A patent/RU2258506C2/ru not_active IP Right Cessation
- 2001-06-12 EE EEP200200698A patent/EE04941B1/xx not_active IP Right Cessation
- 2001-06-12 WO PCT/JP2001/004934 patent/WO2001098300A1/ja active IP Right Grant
- 2001-06-12 CN CNB018142834A patent/CN100354274C/zh not_active Expired - Fee Related
- 2001-06-12 KR KR1020027017221A patent/KR20030010740A/ko not_active Application Discontinuation
- 2001-06-12 CZ CZ20024153A patent/CZ20024153A3/cs unknown
- 2001-06-12 SK SK1768-2002A patent/SK17682002A3/sk unknown
- 2001-06-12 PL PL363869A patent/PL200537B1/pl not_active IP Right Cessation
- 2001-06-12 US US10/311,932 patent/US6743803B2/en not_active Expired - Fee Related
- 2001-06-12 AU AU2001262741A patent/AU2001262741B2/en not_active Ceased
- 2001-06-12 NZ NZ523189A patent/NZ523189A/en unknown
- 2001-06-12 HU HU0301319A patent/HUP0301319A3/hu unknown
- 2001-06-12 MX MXPA02012599A patent/MXPA02012599A/es active IP Right Grant
-
2002
- 2002-12-15 IL IL153439A patent/IL153439A/en not_active IP Right Cessation
- 2002-12-20 NO NO20026148A patent/NO20026148L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL153439A (en) | 2007-07-24 |
EP1295883A1 (en) | 2003-03-26 |
EE200200698A (et) | 2004-08-16 |
PL200537B1 (pl) | 2009-01-30 |
NZ523189A (en) | 2004-08-27 |
TWI298068B (en) | 2008-06-21 |
US20030166673A1 (en) | 2003-09-04 |
AU2001262741B2 (en) | 2005-07-07 |
PL363869A1 (en) | 2004-11-29 |
WO2001098300A1 (fr) | 2001-12-27 |
IL153439A0 (en) | 2003-07-06 |
CN1447809A (zh) | 2003-10-08 |
NO20026148D0 (no) | 2002-12-20 |
SK17682002A3 (sk) | 2003-08-05 |
KR20030010740A (ko) | 2003-02-05 |
CN100354274C (zh) | 2007-12-12 |
BR0111799A (pt) | 2003-05-27 |
EP1295883A4 (en) | 2003-06-11 |
MXPA02012599A (es) | 2003-05-14 |
AU6274101A (en) | 2002-01-02 |
CA2412199A1 (en) | 2001-12-27 |
HUP0301319A3 (en) | 2008-06-30 |
US6743803B2 (en) | 2004-06-01 |
HUP0301319A2 (hu) | 2003-09-29 |
RU2258506C2 (ru) | 2005-08-20 |
NO20026148L (no) | 2003-02-20 |
CZ20024153A3 (cs) | 2003-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60121992D1 (de) | Zusammensetzung zur verabreichung und beschichtung medizinischer geräte | |
EE200300145A (et) | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon | |
EP1399171A4 (en) | MEDICINAL HERB COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DIABETES | |
DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
NO20006630D0 (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
DE60232251D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
EE200200628A (et) | Dihüdroksüestrite ja nende derivaatide valmistamismeetod | |
ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
EE200200717A (et) | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid | |
EE200200271A (et) | Ravimkombinatsioonid ning nende kasutamine | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
GB0004531D0 (en) | The treatment of respiratory diseases | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
FI20001985A (fi) | Laitteisto ja menetelmä palautuspullojen käsittelyssä | |
EE04941B1 (et) | Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine | |
NO20020784D0 (no) | Medikament for behandling av brudd | |
PT1152756E (pt) | Derivados de anticonvulsivo uteis no tratamento do autismo | |
AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
FR2800614B1 (fr) | Composition pour le traitement des infections des voies respiratoires | |
EE200300057A (et) | Koostis vähi profülaktikaks ja raviks | |
IL137275A0 (en) | Pharmaceutical composition for the treatment of anal fissures | |
NO20032769D0 (no) | Kombinasjonsmetode for behandling av virale infeksjoner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB1A | Change in the ownership or in the address of the owner | ||
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20090612 |